Last Updated : August 29, 2008
Details
FilesGeneric Name:
Abatacept
Project Status:
Complete
Therapeutic Area:
Arthritis, Juvenile Idiopathic & Juvenile Rheumatoid
Manufacturer:
Bristol-Myers Squibb Canada
Brand Name:
Orencia
Project Line:
Reimbursement Review
Project Number:
SR0145-000
Submission Type:
Initial
Indications:
Arthritis, Juvenile Idiopathic & Juvenile Rheumatoid
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : August 29, 2008